Insider · CIK 0001287235

TIDMARSH GEORGE F

Reports to the SEC for 6 companies · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001287235

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-11	REVBREVELATION BIOSCIENCES, INC.A Award	Director	AAward	+181 sh	$3.87	+$700.47	268
2023-12-08	REVBREVELATION BIOSCIENCES, INC.S Sale	Director	SSale	−27.8K sh	$0.52	−$14.4K	0
2023-10-16	REVBREVELATION BIOSCIENCES, INC.S Sale	Director	SSale	−11K sh	$0.66	−$7,242.577	42,096
2023-10-16	REVBREVELATION BIOSCIENCES, INC.S Sale	Director	SSale	−1,845 sh	$0.65	−$1,199.435	27,771
2023-09-28	REVBREVELATION BIOSCIENCES, INC.S Sale	Director	SSale	−1,429 sh	$0.69	−$986.01	42,096
2023-09-18	REVBREVELATION BIOSCIENCES, INC.S Sale	Director	SSale	−4,000 sh	$0.74	−$2,960	39,348
2023-09-15	REVBREVELATION BIOSCIENCES, INC.S Sale	Director	SSale	−9,500 sh	$0.73	−$6,935	43,348
2023-09-14	REVBREVELATION BIOSCIENCES, INC.S Sale	Director	SSale	−12K sh	$0.75	−$9,000	52,848
2023-04-18	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+25K sh	$1.16	+$29K	64,848
2023-04-17	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+26.5K sh	$1.16	+$30.7K	39,848
2023-04-14	REVBREVELATION BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,356 sh	—	—	6,356
2022-02-25	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+20K sh	$1.60	+$32K	467,156
2022-02-09	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+30K sh	$2.55	+$76.6K	447,156
2022-02-08	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+1,000 sh	$2.54	+$2,540	417,156
2022-02-07	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+42.1K sh	$2.61	+$110K	1,523,335
2022-02-07	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+42.1K sh	$2.61	+$110K	1,523,335
2022-02-04	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+7,900 sh	$2.31	+$18.3K	1,481,235
2022-02-04	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+7,900 sh	$2.31	+$18.3K	1,481,235
2022-02-04	REVBREVELATION BIOSCIENCES, INC.P Purchase	Director	PPurchase	+2,000 sh	$2.45	+$4,900	416,156
2019-09-19	Odonate Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+77.3K sh	—	—	77,331
2019-09-19	Odonate Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+74K sh	—	—	151,291
2019-09-19	Odonate Therapeutics, Inc.Incentive UnitsM Exercise/Conversion	Director	MExercise/Conversion	−78.8K sh	—	—	43,225
2019-09-19	Odonate Therapeutics, Inc.Incentive UnitsM Exercise/Conversion	Director	MExercise/Conversion	−75.4K sh	—	—	49,391
2019-04-15	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+2 sh	$6.09	+$12.18	1,263,895
2019-04-15	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+2 sh	—	—	2
2019-03-29	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+94 sh	$5.47	+$514.18	1,263,893
2019-03-29	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+94 sh	—	—	94
2019-03-15	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+195 sh	$6.49	+$1,265.55	1,263,799
2019-03-15	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+195 sh	—	—	195
2019-02-28	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+261 sh	$4.85	+$1,265.85	1,263,604
2019-02-28	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+261 sh	—	—	261
2019-02-15	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+239 sh	$5.30	+$1,266.7	1,263,343
2019-02-15	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+239 sh	—	—	239
2019-01-31	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+246 sh	$5.13	+$1,261.98	1,284,446
2019-01-31	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+246 sh	—	—	246
2019-01-23	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+174K sh	—	—	174,000
2019-01-15	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+874 sh	$5.74	+$5,016.76	1,284,200
2019-01-15	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+874 sh	—	—	874
2019-01-07	LA JOLLA PHARMACEUTICAL COP Purchase	Director, President, CEO & Secretary	PPurchase	+82 sh	$5.85	+$479.7	1,281,408
2019-01-07	LA JOLLA PHARMACEUTICAL COP Purchase	Director, President, CEO & Secretary	PPurchase	+287 sh	$5.85	+$1,678.95	1,281,695
2019-01-07	LA JOLLA PHARMACEUTICAL COP Purchase	Director, President, CEO & Secretary	PPurchase	+98 sh	$5.85	+$573.3	1,281,793
2019-01-07	LA JOLLA PHARMACEUTICAL COP Purchase	Director, President, CEO & Secretary	PPurchase	+397 sh	$5.85	+$2,322.45	1,282,190
2019-01-07	LA JOLLA PHARMACEUTICAL COP Purchase	Director, President, CEO & Secretary	PPurchase	+700 sh	$5.85	+$4,095	1,282,890
2019-01-07	LA JOLLA PHARMACEUTICAL COP Purchase	Director, President, CEO & Secretary	PPurchase	+436 sh	$5.85	+$2,550.6	1,283,326
2018-12-31	Odonate Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2018-12-31	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+154 sh	$8.02	+$1,234.387	1,281,326
2018-12-31	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+154 sh	—	—	154
2018-12-14	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+112 sh	$10.88	+$1,218.56	1,281,172
2018-12-14	LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award	Director, President, CEO & Secretary	AAward	+112 sh	—	—	112
2018-11-30	LA JOLLA PHARMACEUTICAL COA Award	Director, President, CEO & Secretary	AAward	+100 sh	$12.30	+$1,229.95	1,281,060

Recent filings

Accepted (ET)
Feb 134
TIDMARSH GEORGE F0000950170-25-020097
SEC(opens sec.gov)
Dec 124
TIDMARSH GEORGE F0001209191-23-058296
SEC(opens sec.gov)
Oct 184
TIDMARSH GEORGE F0001209191-23-053102
SEC(opens sec.gov)
Oct 174
TIDMARSH GEORGE F0001209191-23-052953
SEC(opens sec.gov)
Oct 24
TIDMARSH GEORGE F0001209191-23-051037
SEC(opens sec.gov)
Sep 184
TIDMARSH GEORGE F0001209191-23-049786
SEC(opens sec.gov)
Apr 194
TIDMARSH GEORGE F0001209191-23-024898
SEC(opens sec.gov)
Apr 184
TIDMARSH GEORGE F0001209191-23-024646
SEC(opens sec.gov)
Feb 284
TIDMARSH GEORGE F0001209191-22-013741
SEC(opens sec.gov)
Feb 104
TIDMARSH GEORGE F0001209191-22-008580
SEC(opens sec.gov)
Feb 94/A
TIDMARSH GEORGE F0001209191-22-008025
SEC(opens sec.gov)
Feb 84
TIDMARSH GEORGE F0001209191-22-007837
SEC(opens sec.gov)
Sep 234
TIDMARSH GEORGE F0001209191-19-050515
SEC(opens sec.gov)

Companies

Address

157 TECHNOLOGY DRIVE

IRVINE, CA, 92618